statistiche ricercatore

Nome	#
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types	60
Novel TLR7/8 ligands activating dendritic cells in infections and autoimmunity	58
SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8	44
Fine-tuning of the immunomodulatory functions of dendritic cells by the Phosphodiestherase 4 inhibitor tanimilast.	37
Inhibition of Class I Histone Deacetylase Activity Blocks the Induction of TNFAIP3 Both Directly and Indirectly via the Suppression of Endogenous TNF-α	34
The PDE4 Inhibitor Tanimilast Blunts Proinflammatory Dendritic Cell Activation by SARS-CoV-2 ssRNAs	33
The PDE4 Inhibitor Tanimilast Restrains the Tissue-Damaging Properties of Human Neutrophils	27
The PDE4 inhibitor tanimilast shows distinct immunomodulatory properties associated with a type 2 endotype and CD141 upregulation	26
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement	18
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity	16
Extracellular vesicles at the crossroad between cancer progression and immunotherapy: focus on dendritic cells	16
Totale	369

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	43	0	0	5	1	2	0	12	2	5	3	2	11
2022/2023	56	5	1	3	2	5	12	0	16	6	0	2	4
2023/2024	145	4	1	6	12	9	16	10	27	24	8	10	18
2024/2025	125	8	6	10	35	32	17	17	0	0	0	0	0
Totale													369